|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400086557 |
|
最近更新日期: Date of Last Refreshed on: |
2024-07-05 09:40:48 |
|
注册时间: Date of Registration: |
2024-07-05 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
接力种策略提升中国青少年女性HPV疫苗接种率:一项三臂整群随机对照试验 |
|
Public title: |
A cluster randomized controlled trial with three arms to implement strategies to increase HPV vaccination coverage among Chinese adolescent girls. |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
接力种策略提升中国青少年女性HPV疫苗接种率:一项三臂整群随机对照试验 |
|
Scientific title: |
Increasing HPV Vaccination Coverage Among Chinese Adolescent Girls: A Cluster Randomized Controlled Trial with Three Arms |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
陆娅胶 |
研究负责人: |
吴丹 |
|
Applicant: |
Lu Yajiao |
Study leader: |
Wu Dan |
|
申请注册联系人电话: Applicant telephone: |
+86 182 8010 3313 |
研究负责人电话:
Study leader's |
+86 25 8686 2389 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
3021560893@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
danwu@njmu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
四川省成都市武侯区人民南路三段17号 |
研究负责人通讯地址: |
南京市江宁区龙眠大道101号 |
|
Applicant address: |
17 Renmin Road South, Wuhou District, Chengdu, China |
Study leader's address: |
101 Longmian Avenue, Jiangning District, Nanjing City. |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
四川大学 |
||
|
Applicant's institution: |
Sichuan University |
||
|
研究负责人所在单位: |
南京医科大学公共卫生学院 |
||
|
Affiliation of the Leader: |
School of Public Health, Nanjing Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
南医大伦审[2024]755号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
南京医科大学伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Nanjing Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-07-04 00:00:00 | ||
|
伦理委员会联系人: |
孙玉龙 |
||
|
Contact Name of the ethic committee: |
Sun Yulong |
||
|
伦理委员会联系地址: |
南京市江宁区龙眠大道101号 |
||
|
Contact Address of the ethic committee: |
101 Longmian Avenue, Jiangning District, Nanjing City. |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 25 8686 9215 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
南京医科大学公共卫生学院 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor: |
School of Public Health, Nanjing Medical University |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
南京市江宁区龙眠大道101号 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor's address: |
101 Longmian Avenue, Jiangning District, Nanjing City. |
||||||||||||||||||||||||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
经费或物资来源: |
比尔及梅琳达·盖茨基金会 |
||||||||||||||||||||||||||||||||||||||||||||
|
Source(s) of funding: |
Bill & Melinda Gates Foundation |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病: |
宫颈癌 |
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease: |
Cervical cancer |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||||||||||||||||||||||||
|
研究设计: |
整群随机分组 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study design: |
Cluster randomization |
||||||||||||||||||||||||||||||||||||||||||||
|
研究目的: |
(1)比较接力种组与津贴组和视频健康教育组之间疫苗接种率差别 (2)比较接力种组与津贴组和视频健康教育组之间疫苗延迟意愿及疫苗信心的差别 (3)分析不同干预措施的成本效果 |
||||||||||||||||||||||||||||||||||||||||||||
|
Objectives of Study: |
(1) Compare the difference in vaccine uptake rates between the relay planting group, subsidy group, and video health education group. (2) Compare the differences in vaccine hesitancy and vaccine confidence between the relay planting group, subsidy group, and video health education group. (3) Analyze the cost-effectiveness of different intervention measures |
||||||||||||||||||||||||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
纳入标准: |
①青少年女性(WHO定义10-18岁);②无HPV疫苗接种史;③既往无严重的、危及生命的疫苗过敏症。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Inclusion criteria |
① Adolescent females (defined by WHO as aged 10-18 years); ② No history of HPV vaccination; ③ No history of severe, life-threatening vaccine allergies. |
||||||||||||||||||||||||||||||||||||||||||||
|
排除标准: |
①患有经临床医生诊断不宜接种疫苗的其他疾病;②自己(满18周岁)或法定监护人(未满18周岁)无法签署知情同意书。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Exclusion criteria: |
① Other diseases diagnosed by a clinical doctor as unsuitable for vaccination; ② Unable to sign an informed consent form themselves (if over 18 years old) or by a legal guardian (if under 18 years old) |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-11-01 00:00:00至 To 2025-10-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-07-12 00:00:00 至 To 2025-07-12 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
研究助理(RA)通过计算机软件SPSS 21.0生成与分组相匹配的随机数字序列,并通过与序列相匹配学校ID号进行随机分组 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The research assistant (RA) utilized computer software SPSS 21.0 to generate randomly matched numerical sequences for grouping. The randomization was performed by matching school ID numbers with the generated sequences. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
行为干预研究中,由于干预者和参与者均知道所采取的干预方法,因此不能全程采用盲法,但我们在重要的实施步骤中尽可能多地采用盲法以减少偏倚:1) 由专门的研究人员生成随机分组,但不知道具体的学校顺序,学校招募的联络人和现场工作人员均不知道学校分组序列;2)直到现场执行前,现场参与者和现场工作人员才知道分配的干预措施;3)学校现场协调员,疫苗接种人员以及结局评估员都不知道参与者所接受的干预; |
|
Blinding: |
In behavioral intervention studies, blinding cannot be fully implemented because both the interveners and participants are aware of the intervention methods. However, we adopt blinding as much as possible in key implementation steps to reduce bias: 1.Random group allocation is performed by specialized researchers who are unaware of the specific school order. Contact persons for school recruitment and on-site staff are also unaware of the school group sequence. 2.On-site participants and staff are informed of the assigned intervention measures only just before on-site execution. 3.School coordinators, vaccine administrators, and outcome assessors are unaware of the interventions received by participants throughout the study |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
与项目结果一同上传公开(开源发表)至某国际期刊 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
We will publish the data files along with the study findings (open access) to an international journal. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
EDC |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Electronic data capture system will be uesd. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |